Evaluation of Same-Day versus Next-Day Implantation of Intracanalicular Dexamethasone for the Control of Postoperative Inflammation and Pain Following Cataract Surgery

Figures & data

Figure 1 The technique for intracanalicular implantation of the insert is shown. Following dilation of the lower canaliculus, the area is dried with a Weck-Cel^® sponge. The insert is then carefully inserted into the lower canaliculus. Following insertion and contact with the tear film, the insert expands and conforms to the canalicular anatomy.

Table 1 Demographic and Clinical Characteristics

Parameter
Age (y), mean ± SD	69.5 ± 9.0
Range (y)	40–87
Sex, n, M/F	14/17
Race, n (%)
White	20 (58)
Hispanic	9 (30)
African-American	1 (6.3)
Asian	1 (6.3)
Baseline IOP (mmHg), mean ± SD
Same-day group	15.5 ± 4.2
POD1 group	15.5 ± 4.0

Abbreviations: IOP, intraocular pressure; SD, standard deviation.

Table 2 Summary of the Presence of Anterior Chamber Inflammation at Each Time Point

Treatment Group	1 Day	1 Week	1 Month
Same Day, n (%)
No. with no inflammation	0 (0)	16 (52)	31 (100)
No. with 0.5+ cell	0 (0)	10 (32)	0 (0)
No. with 1+ cell	15 (48)	5 (16)	0 (0)
No. with 2+ cell	16 (52)	0 (0)	0 (0)
Postoperative Day 1, n (%)
No. with no inflammation	0 (0)	18 (5)	30 (97)
No. with 0.5+ cell	1 (3)	11 (36)	1 (3)
No. with 1+ cell	7 (23)	2 (6)	0 (0)
No. with 2+ cell	23 (74)	0 (0)	0 (0)

Note: At each time point, anterior chamber inflammation, quantitatively assessed by cells and flare, was graded 0–4+ based on the Standardization of Uveitis Nomenclature (SUN) grading scheme on slit-lamp biomicroscopy.